Skip Nav Destination
Monitoring Targeted Therapy: Is Fluorodeoxylucose Uptake a Marker of Early Response?
Clin Cancer Res (2006) 12 (19): 5608–5610.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Yi-Hsiu Chung
- Tsai-Hsien Hung
- Ching-Fang Yu
- Cheng-Kun Tsai
- Chi-Chang Weng
- Fujie Jhang
- Fang-Hsin Chen
- Gigin Lin
Metabolites (2023) 13 (1): 110.
- Michael D. Farwell
- Daniel A. Pryma
- David A. Mankoff
Cancer (2014) 120 (22): 3433.
- J. Lawrence
- E. Rohren
- J. Provenzale
Veterinary and Comparative Oncology no.
- John O. Prior
- Michael Montemurro
- Maria-Victoria Orcurto
- Olivier Michielin
- François Luthi
- Jean Benhattar
- Louis Guillou
- Valérie Elsig
- Roger Stupp
- Angelika Bischof Delaloye
- Serge Leyvraz
Journal of Clinical Oncology (2009) 27 (3): 439.
- D.A. Mankoff
Breast Diseases: A Year Book Quarterly (2008) 19 (3): 233.
- David A. Mankoff
- Jeanne M. Link
- Hannah M. Linden
- Lavanya Sundararajan
- Kenneth A. Krohn
Journal of Nuclear Medicine (2008) 49 (Suppl 2): 149S.
- Giovanni Lucignani
European Journal of Nuclear Medicine and Molecular Imaging (2007) 34 (4): 596.
Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
- David A. Mankoff
- Janet F. Eary
- Jeanne M. Link
- Mark Muzi
- Joseph G. Rajendran
- Alexander M. Spence
- Kenneth A. Krohn
Clinical Cancer Research (2007) 13 (12): 3460.
- Jean H. Lee
- Lavanya Sundararajan
- William B. Eubank
- David A. Mankoff
Seminars in Breast Disease (2006) 9 (4): 146.
